Abstract
Carbamazepine (CBZ) is one of the most widely prescribed anticonvulsants despite a high incidence of idiosyncratic side effects. Metabolism of CBZ is complex, and of the more than 30 metabolites identified, one of the most abundant is CBZ N-glucuronide. To date the uridine diphosphate glucuronosyltransferase (UGT) isoform responsible for the N-glucuronidation of CBZ has not been identified. We have developed a sensitive liquid chromatography/mass spectrometry assay to quantify CBZ glucuronidation, and we report that CBZ is specifically glucuronidated by human UGT2B7. Kinetics of CBZ glucuronidation in human liver, kidney, and intestine microsomes were consistent with those of recombinant UGT2B7, which displayed a Km value of 214 μM and Vmax value of 0.79 pmol/mg/min. In addition to revealing the isoform responsible for CBZ glucuronidation, this is the first example of primary amine glucuronidation by UGT2B7.
Footnotes
-
This work was supported by a grant from the Wellcome Trust (to B.B. and M.W.H.C.).
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.104.073114.
-
ABBREVIATIONS: CBZ, carbamazepine (5H-dibenzo[b,f]azepine-5-carboxamide); UGT, uridine diphosphate glucuronosyltransferase; LC/MS, liquid chromatography/mass spectrometry; HPLC, high-performance liquid chromatography; UDPGA, β-d-uridine diphosphoglucuronic acid; LC/MS-MS, liquid chromatography-tandem mass spectrometry; LC, liquid chromatography; SRM, single reaction monitoring.
- Received June 24, 2004.
- Accepted July 30, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|